NCT03492762View on ClinicalTrials.gov

PET Imaging CCR2 in Lung Inflammation

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

February 27, 2018

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Lung Inflammation
Interventions
DRUG

Cu-DOTA-ECL1i

Radiolabeled probe called Cu-DOTA-ECL1i that recognizes CCR2 and propose to image CCR2 in the lung to ultimately guide diagnosis and therapy.

Trial Locations (1)

63110

RECRUITING

Washington University School of Medicine, St Louis

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Washington University School of Medicine

OTHER